Parents fight as company discontinues drug for 'childhood Alzheimer's'

  • 📰 TODAYshow
  • ⏱ Reading Time:
  • 26 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 55%

대한민국 뉴스 뉴스

대한민국 최근 뉴스,대한민국 헤드 라인

Parents say they believe this drug is helping their children; the drug company says research doesn't show a benefit.

in the hopes that another company will take over making the medication that she believes has transformed Marian’s life.Jenna Weets’ son Jeg was diagnosed in 2017. After learning about adrabetadex, she felt hopeful.

Serrano Russi treats Marian and says that the future for children with NPC will be murky after adrabetadex is no longer available.Marian McGlockin, 5, is a "dynamo" who tells knock-knock jokes and plays babysitter with her dolls. When she was first diagnosed with Niemann Pick Type C, she was already losing her ability to speak.remains frustrating. Researchers face challenges because there are fewer people to study, and the condition may progress very differently in different people.

이 소식을 빠르게 읽을 수 있도록 요약했습니다. 뉴스에 관심이 있으시면 여기에서 전문을 읽으실 수 있습니다. 더 많은 것을 읽으십시오:

 /  🏆 389. in KR
 

귀하의 의견에 감사드립니다. 귀하의 의견은 검토 후 게시됩니다.

대한민국 최근 뉴스, 대한민국 헤드 라인